Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers

CDKN2A-p16-Leiden mutation carriers have a substantial risk of developing pancreatic ductal adenocarcinoma (PDAC). One of the main clinical features of hereditary cancer is the development of multiple cancers. Since 2000, we have run a surveillance program for CDKN2A-p16-Leiden mutation carriers. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hum Genet
Main Authors: Ibrahim, Isaura, Sibinga Mulder, Babs G., Bonsing, Bert, Morreau, Hans, Farina Sarasqueta, Arantza, Inderson, Akin, Luelmo, Saskia, Feshtali, Shirin, Potjer, Thomas P., de Vos tot Nederveen Cappel, Wouter, Wasser, Martin, Vasen, Hans F. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6057932/
https://ncbi.nlm.nih.gov/pubmed/29769629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41431-018-0170-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados